Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Nina Caculitan, GaYeon Kim, Ann Woolfrey, Luke P. Akard, Ah-Reum Jeong, Jack Khouri, Gunjan L. Shah, Pina M. Cardarelli

Blood (2024) 144 (Supplement 1): 4858.

https://doi.org/10.1182/blood-2024-208805

Published: 2024

Journal Articles

Trial in Progress: An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with and without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Nina Caculitan, Josephine M. Cardarelli, Jack Khouri, Hyung C Suh, Muthalagu Ramanathan, Ann Woolfrey

Blood (2023) 142 (Supplement 1): 7082.

https://doi.org/10.1182/blood-2023-187191

Published: 2023

Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD

Blood (2019) 134 (Supplement_1): 369.

https://doi.org/10.1182/blood-2019-123196

Published: 2019

Journal Articles

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Monica S. Thakar, Larisa Broglie, Brent Logan, Andrew Artz, Nancy Bunin, Lauri M. Burroughs, Caitrin Fretham, David A. Jacobsohn, Alison W. Loren, Joanne Kurtzberg, Caridad A. Martinez, Shin Mineishi, Adam S. Nelson, Ann Woolfrey, Marcelo C. Pasquini, Mohamed L. Sorror

Blood (2019) 133 (7): 754–762.

https://doi.org/10.1182/blood-2018-09-876284

Published: 2019

Includes: Supplemental data

Journal Articles

From Bone Marrow to Mobilized Peripheral Blood Stem Cells: The Circuitous Path to Clinical Gene Therapy for Fanconi Anemia

Pamela S Becker, MD PhD, Jennifer Adair, PhD, Grace Choi, BS, Anne Lee, Ann Woolfrey, MD, Lauri S Burroughs, MD, Kanwaldeep K. Mallhi, MD, Amy E. Geddis, MD PhD, Hans-Peter Kiem, MD PhD

Blood (2018) 132 (Supplement 1): 2208.

https://doi.org/10.1182/blood-2018-99-120278

Published: 2018

Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Blood (2017) 130 (Supplement 1): 848.

https://doi.org/10.1182/blood.V130.Suppl_1.848.848

Published: 2017

Journal Articles

Novel Lineage Depletion and Manufacturing Allows for Unprecedented Preservation of Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group Α

Jennifer Adair, PhD, Devikha Chandrasekaran, MS, Stefanie Schmuck, BS, Gabriella Sghia-Hughes, BS, Grace Choi, BS, Anne Lee, BS, Kevin G Haworth, BS, PhD, Ann Woolfrey, MD, Lauri S Burroughs, MD, Pamela S. Becker, MD PhD, Hans-Peter Kiem, MD PhD

Blood (2017) 130 (Supplement 1): 2451.

https://doi.org/10.1182/blood.V130.Suppl_1.2451.2451

Published: 2017

Journal Articles

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

Blood (2016) 128 (3): 440–448.

https://doi.org/10.1182/blood-2016-03-704015

Published: 2016

Journal Articles

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Blood (2014) 123 (8): 1270–1278.

https://doi.org/10.1182/blood-2013-10-532671

Published: 2014

Includes: Supplemental data

Journal Articles

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors

Carolyn Katovich Hurley, Ann Woolfrey, Tao Wang, Michael Haagenson, John Umejiego, Mahmoud Aljurf, Medhat Askar, Minoo Battiwalla, Jason Dehn, John Horan, Machteld Oudshoorn, Joseph Pidala, Wael Saber, Victoria Turner, Stephanie J. Lee, Stephen R. Spellman

Blood (2013) 121 (23): 4800–4806.

https://doi.org/10.1182/blood-2013-01-480343

Published: 2013

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

John Horan, Tao Wang, Michael Haagenson, Stephen R. Spellman, Jason Dehn, Mary Eapen, Haydar Frangoul, Vikas Gupta, Gregory A. Hale, Carolyn K. Hurley, Susana Marino, Machteld Oudshoorn, Vijay Reddy, Peter Shaw, Stephanie J. Lee, Ann Woolfrey

Blood (2012) 120 (14): 2918–2924.

https://doi.org/10.1182/blood-2012-03-417758

Published: 2012

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial

Blood (2011) 118 (21): 1.

https://doi.org/10.1182/blood.V118.21.1.1

Published: 2011

Journal Articles

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Edmund K Waller, MD PhD, Wayne A.C. Harris, Steven Devine, David L. Porter, MD, Shin Mineishi, MD, John M. McCarty, MD, Corina E Gonzalez, MD, Thomas R Spitzer, MD, Oleg I. Krijanovski, PhD, MD, Michael L. Linenberger, MD, Ann Woolfrey, MD, Alan Howard, PhD, Cathy Gurgol, Brent R. Logan, PhD, Dennis L Confer, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 1004.

https://doi.org/10.1182/blood.V118.21.1004.1004

Published: 2011

Journal Articles

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Claudio Brunstein, MD, Mary Eapen, MBBS, Kwang w Ahn, PhD, Frederick R. Appelbaum, MD, Karen K Ballen, MD, Richard Champlin, Fangyu Kan, MS, Mary J. Laughlin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, John E. Wagner, MD

Blood (2010) 116 (21): 908.

https://doi.org/10.1182/blood.V116.21.908.908

Published: 2010

Journal Articles

RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia

Karen K Ballen, MD, Mukta Arora, MD, Xiaochun Zhu, MS, Manza Agovi, Matt Kalaycio, MD, Richard T Maziarz, MD, Jorge E. Cortes, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, Wael Saber, MD, MS

Blood (2010) 116 (21): 3514.

https://doi.org/10.1182/blood.V116.21.3514.3514

Published: 2010

Journal Articles

Breaking barriers

Ann Woolfrey

Blood (2010) 115 (6): 1112.

https://doi.org/10.1182/blood-2009-11-254987

Published: 2010

Journal Articles

Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors.

Claudio G. Brunstein, Jonathan A Gutman, Todd E. DeFor, Ted Gooley, Michael R Verneris, Ann Woolfrey, Daniel J. Weisdorf, MD, Frederick R Appelbaum, John E. Wagner, Colleen Delaney

Blood (2009) 114 (22): 662.

https://doi.org/10.1182/blood.V114.22.662.662

Published: 2009

Journal Articles

A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial.

Brenda M. Sandmaier, MD, Michael Maris, MD, Barry Storer, PhD, Lars Vindelov, MD, Amelia Langston, MD, James C. Wade, MD, MPH, Wolfgang A. Bethge, MD, Michael Pulsipher, MD, Thoralf Lange, MD, Thomas Chauncey, MD, Finn Petersen, MD, Kai Hübel, MD, Ann Woolfrey, MD, Mary E.D. Flowers, MD, David G. Maloney, MD, PhD, Rainer F. Storb, MD

Blood (2009) 114 (22): 348.

https://doi.org/10.1182/blood.V114.22.348.348

Published: 2009

NARROW

An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Trial in Progress: An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with and without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

From Bone Marrow to Mobilized Peripheral Blood Stem Cells: The Circuitous Path to Clinical Gene Therapy for Fanconi Anemia

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Novel Lineage Depletion and Manufacturing Allows for Unprecedented Preservation of Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group Α

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia

Breaking barriers

Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only